Ketamine Pills for Depression: Trial Results Expose Surprising Truths About Psychedelic Therapy
Auckland, New Zealand – Researchers in New Zealand are exploring the potential benefits of using slow-release oral doses of ketamine as a therapy for treatment-resistant depression following a failed attempt at using MDMA therapy for post-traumatic stress disorder. The mid-stage clinical trial conducted by Douglas Pharmaceuticals showed promising results in terms of safety and efficacy of ketamine compared to a placebo. The trial, which included 231 participants, aimed to address the limited pool of patients …